Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eric Larsen

Podiatrist Creston, IA Doctor of Podiatric Medicine

NPI 1912293135 CMS profile 474917

1610 W Townline St, Creston, IA 50801

Open in the dashboard

General payments

$10,198

103 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eric Larsen of Creston, IA is reported in the CMS Open Payments database as having received $10,198 across 103 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $626 13
2024 General $1,701 22
2023 General $242 7
2022 General $989 8
2021 General $251 9
2020 General $146 9
2019 General $6,244 35

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Larsen
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to Eric Larsen were reported at $626. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year Eric Larsen Podiatrist median Middle half National median
2019 $6,244 $196 $72–$601 $163
2020 $146 $118 $38–$335 $114
2021 $251 $169 $57–$573 $132
2022 $989 $220 $74–$782 $149
2023 $242 $208 $71–$635 $160
2024 $1,701 $237 $87–$681 $164
2025 $626 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Horizon Therapeutics plc $4,331 12 payments
  2. Stryker Corporation $1,267 29 payments
  3. Arthrex, Inc. $1,113 3 payments
  4. DePuy Synthes Sales Inc. $1,084 9 payments
  5. Medical Device Business Services, Inc. $942 6 payments
  6. Smith+Nephew, Inc. $169 8 payments
  7. MIMEDX Group, Inc. $169 1 payment
  8. Acell, Inc. $124 1 payment
  9. Wright Medical Technology, Inc. $120 3 payments
  10. Paragon 28, Inc. $119 4 payments
  11. Other $760 27 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,480 93 payments
  2. Honoraria $3,000 1 payment
  3. Travel and Lodging $2,633 8 payments
  4. Education $1,085 1 payment
Products named General payments · program years 2019–2025
  1. KRYSTEXXA $4,331 12 payments
  2. MOTOBAND $947 5 payments
  3. AUGMENT INJECTABLE $410 4 payments
  4. VARIAX $238 7 payments
  5. 7 X 23MM CITRELOCK IMPLANT $174 1 payment
  6. ORTHOLOC 3DI $165 3 payments
  7. BME NITINOL CONTINUOUS COMPRESSION IMPLANTS $138 4 payments
  8. Integra Recon-Skin And Wound $104 2 payments
  9. Integra Recon-Skin And Wound $104 2 payments
  10. PRIMATRIX $104 2 payments
  11. Other $1,910 79 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

125

Median for Podiatry: 160

Drug cost

$1,074

Median for Podiatry: $2,368

Branded share of claims

10.4%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ketoconazole Generic 23 $482
Allopurinol Generic 49 $301
Methylprednisolone Generic 22 $121
Cephalexin Generic 18 $110
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 13 $60

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 16 billing codes

Paid by Medicare

$2,252

Medicare's payments for the services billed

Medicare patients

15

Average age 71

Services billed

25

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

103 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist in Iowa

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record